CUVITRU

This brand name is authorized in Austria, Brazil, France, Hong Kong, Ireland, Netherlands, Poland, Turkey, United Kingdom, United States

Active ingredients

The drug CUVITRU contains one active pharmaceutical ingredient (API):

1 Human normal immunoglobulin G UNII 66Y330CJHS - HUMAN IMMUNOGLOBULIN G

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. Human normal immunoglobulin contains the IgG antibodies present in the normal population. It is usually prepared from pooled plasma from not fewer than 1000 donors. Read about Human normal immunoglobulin G

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CUVITRU Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BA01	Immunoglobulins, normal human, for extravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 540219070004407, 540219070004507, 540219070004607, 540219070004707
Country: FR	Base de données publique des médicaments	Identifier(s): 63172629
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 346903, 346905, 346907, 346910, 394862
Country: HK	Department of Health Drug Office	Identifier(s): 67044
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 139246, 201510, 97381, 97403, 97411
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100376653
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681429550394, 8681429550400, 8681429550417, 8681429550424
Country: US	FDA, National Drug Code	Identifier(s): 0944-2850